Literature DB >> 31914220

Interaction between APOE4 and herpes simplex virus type 1 in Alzheimer's disease.

Morgane Linard1, Luc Letenneur1, Isabelle Garrigue2, Angélique Doize2, Jean-François Dartigues1, Catherine Helmer1,3.   

Abstract

INTRODUCTION: Numerous results suggest the implication of infectious agents in the onset of Alzheimer's disease (AD).
METHODS: In the Bordeaux-3C prospective cohort, we assessed the impact of herpes simplex virus type 1 (HSV-1) infection on the incidence of AD according to apolipoprotein E (APOE) status, a genetic susceptibility factor. Cox models were performed to estimate the 10-year risk of AD associated with anti-HSV antibodies in 1037 participants according to APOE4 status.
RESULTS: Among APOE4 carriers, subjects for whom the frequency of HSV-1 reactivation is supposed to be high, that is, immunoglobulin M (IgM) positive or elevated levels of IgG, had an increased risk of AD with adjusted hazard ratios (HRs) of 3.68 (1.08-12.55) and 3.28 (1.19-9.03), respectively. No significant association was found in APOE4-negative subjects. DISCUSSION: These results, in accordance with a solid pathophysiological rationale, suggest a role for HSV-1 in AD development among subjects with a genetic susceptibility factor, the APOE4 allele.
© 2020 the Alzheimer's Association.

Entities:  

Keywords:  APOE4; Alzheimer's disease; dementia; genetic susceptibility; herpes virus; prevention

Year:  2020        PMID: 31914220     DOI: 10.1002/alz.12008

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  30 in total

1.  Cerebral Organoids for Modeling of HSV-1-Induced-Amyloid β Associated Neuropathology and Phenotypic Rescue.

Authors:  Haowen Qiao; Wen Zhao; Moujian Guo; Lili Zhu; Tao Chen; Jibo Wang; Xiaodong Xu; Zhentao Zhang; Ying Wu; Pu Chen
Journal:  Int J Mol Sci       Date:  2022-05-26       Impact factor: 6.208

Review 2.  Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer's Disease.

Authors:  Amy R Nelson
Journal:  Front Aging Neurosci       Date:  2022-04-18       Impact factor: 5.702

3.  Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease.

Authors:  Tamàs Fülöp; Usma Munawara; Anis Larbi; Mathieu Desroches; Serafim Rodrigues; Michele Catanzaro; Andrea Guidolin; Abdelouahed Khalil; François Bernier; Annelise E Barron; Katsuiku Hirokawa; Pascale B Beauregard; David Dumoulin; Jean-Philippe Bellenger; Jacek M Witkowski; Eric Frost
Journal:  CNS Drugs       Date:  2020-07       Impact factor: 6.497

4.  Patterns of Herpes Simplex Virus 1 Infection in Neural Progenitor Cells.

Authors:  Wenxiao Zheng; Alissa M Klammer; Jennifer N Naciri; Jason Yeung; Matthew Demers; Jadranka Milosevic; Paul R Kinchington; David C Bloom; Vishwajit L Nimgaonkar; Leonardo D'Aiuto
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

5.  Multiple Herpes Simplex Virus-1 (HSV-1) Reactivations Induce Protein Oxidative Damage in Mouse Brain: Novel Mechanisms for Alzheimer's Disease Progression.

Authors:  Virginia Protto; Antonella Tramutola; Marco Fabiani; Maria Elena Marcocci; Giorgia Napoletani; Federica Iavarone; Federica Vincenzoni; Massimo Castagnola; Marzia Perluigi; Fabio Di Domenico; Giovanna De Chiara; Anna Teresa Palamara
Journal:  Microorganisms       Date:  2020-06-29

Review 6.  The Use of Antimicrobial and Antiviral Drugs in Alzheimer's Disease.

Authors:  Umar H Iqbal; Emma Zeng; Giulio M Pasinetti
Journal:  Int J Mol Sci       Date:  2020-07-12       Impact factor: 5.923

Review 7.  Anterograde Neuronal Circuit Tracers Derived from Herpes Simplex Virus 1: Development, Application, and Perspectives.

Authors:  Dong Li; Hong Yang; Feng Xiong; Xiangmin Xu; Wen-Bo Zeng; Fei Zhao; Min-Hua Luo
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

8.  The APOE gene cluster responds to air pollution factors in mice with coordinated expression of genes that differs by age in humans.

Authors:  Amin Haghani; Max Thorwald; Todd E Morgan; Caleb E Finch
Journal:  Alzheimers Dement       Date:  2020-11-20       Impact factor: 21.566

9.  Antiviral treatment associated with reduced risk of clinical Alzheimer's disease-A nested case-control study.

Authors:  Eva-Stina Hemmingsson; Ellen Hjelmare; Bodil Weidung; Jan Olsson; Maria Josefsson; Rolf Adolfsson; Lars Nyberg; Fredrik Elgh; Hugo Lövheim
Journal:  Alzheimers Dement (N Y)       Date:  2021-06-09

Review 10.  Overwhelming Evidence for a Major Role for Herpes Simplex Virus Type 1 (HSV1) in Alzheimer's Disease (AD); Underwhelming Evidence against.

Authors:  Ruth F Itzhaki
Journal:  Vaccines (Basel)       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.